| Bioengineered protein-based nanocage for drug delivery EJ Lee, NK Lee, IS Kim Advanced drug delivery reviews 106, 157-171, 2016 | 240 | 2016 |
| Nanocage‐therapeutics prevailing phagocytosis and immunogenic cell death awakens immunity against cancer EJ Lee, GH Nam, NK Lee, M Kih, E Koh, YK Kim, Y Hong, S Kim, SY Park, ... Advanced Materials 30 (10), 1705581, 2018 | 77 | 2018 |
| Ferritin–a multifaceted protein scaffold for biotherapeutics NK Lee, S Cho, IS Kim Experimental & molecular medicine 54 (10), 1652-1657, 2022 | 65 | 2022 |
| Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics NK Lee, EJ Lee, S Kim, G Nam, M Kih, Y Hong, C Jeong, Y Yang, Y Byun, ... Journal of Controlled Release 267, 172-180, 2017 | 50 | 2017 |
| Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion JU Choi, R Maharjan, R Pangeni, SK Jha, NK Lee, S Kweon, HK Lee, ... Journal of Controlled Release 322, 13-30, 2020 | 36 | 2020 |
| Designed trimer-mimetic TNF superfamily ligands on self-assembling nanocages M Kih, EJ Lee, NK Lee, YK Kim, KE Lee, C Jeong, Y Yang, DH Kim, ... Biomaterials 180, 67-77, 2018 | 32 | 2018 |
| A novel oral metronomic chemotherapy provokes tumor specific immunity resulting in colon cancer eradication in combination with anti-PD-1 therapy R Maharjan, JU Choi, S Kweon, R Pangeni, NK Lee, SJ Park, KY Chang, ... Biomaterials 281, 121334, 2022 | 21 | 2022 |
| Protein-based nanocages for vaccine development SA Kim, Y Lee, Y Ko, S Kim, GB Kim, NK Lee, W Ahn, N Kim, GH Nam, ... Journal of Controlled Release 353, 767-791, 2023 | 19 | 2023 |
| Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancer NK Lee, JU Choi, HR Kim, SW Chung, YG Ko, YS Cho, SJ Park, EJ Lee, ... Biomaterials 277, 121105, 2021 | 19 | 2021 |
| Exosomes and Cancer Stem Cells in Cancer Immunity: Current Reports and Future Directions NK Lee, VK Kothandan, S Kothandan, Y Byun, SR Hwang Vaccines 9 (5), 441, 2021 | 17 | 2021 |
| Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia JU Choi, NK Lee, H Seo, SW Chung, TA Al-Hilal, SJ Park, S Kweon, ... Journal for Immunotherapy of Cancer 9 (8), 2021 | 12 | 2021 |
| Dual mechanistic TRAIL nanocarrier based on PEGylated heparin taurocholate and protamine which exerts both pro-apoptotic and anti-angiogenic effects JU Choi, J Kim, SW Chung, NK Lee, J Park, S Kweon, YS Cho, HR Kim, ... Journal of Controlled Release 336, 181-191, 2021 | 11 | 2021 |
| Feedback amplification of senolysis using caspase-3-cleavable peptide-doxorubicin conjugate and 2DG JC Lee, GC Kim, NK Lee, SW Kim, YS Cho, SW Chung, YS Lee, ... Journal of Controlled Release 346, 158-168, 2022 | 8 | 2022 |
| Immune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathway SJ Park, S Kweon, MK Moyo, HR Kim, JU Choi, NK Lee, R Maharjan, ... Biomaterials, 122625, 2024 | 3 | 2024 |
| Stimulating macropinocytosis of peptide-drug conjugates through DNA-dependent protein kinase inhibition for treating KRAS-mutant cancer HR Kim, SJ Park, YS Cho, MK Moyo, JU Choi, NK Lee, SW Chung, ... Journal of Controlled Release 372, 176-193, 2024 | 1 | 2024 |
| to-editor,“Feedback amplification of senolysis using caspase-cleavable peptide-doxorubicin conjugate and 2DG”[Journal of Controlled Release, Volume 346, pp. 158-168,(2022 JC Lee, GC Kim, SW Kim, NK Lee, YS Cho, SW Chung, YS Lee, MW Han, ... Journal of Ophthalmology Clinics and Research 362, 779-783, 2023 | | 2023 |
| Enhancing Tumor Perfusion Using Orally Active Heparin to Improve the Efficacy of Immunotherapy JU CHOI, NK LEE, SEO Hyungseok, SW CHUNG, TA AL-HILAL, ... 한국생물공학회 학술대회, 27-27, 2022 | | 2022 |
| Nanocage therapeutics FHSIRPα mediating immune checkpoint blockade awakens immunity against cancer with an albumin-binding caspase-cleavable doxorubicin prodrug EMC-DEVD-S-DOX NK Lee, JU Choi, JJ Park, JH Seo, MR Kim, HW Chang, SY Kim, IS Kim, ... Cancer Research 79 (13_Supplement), 2251-2251, 2019 | | 2019 |
| Nanocage therapeutics mediating immune checkpoint blockade awakens immunity against cancer with an immunogenic cell death (ICD)-inducing doxorubicin prodrug YB NK Lee, JU Choi, JJ Park, J-H Seo, MR Kim, HW Chang, SY Kim, I-S Kim American Association for Cancer Research, 2019 | | 2019 |
| Nanocage therapeutics mediating immune checkpoint blockade awakens immunity against cancer with an immunogenic cell death (ICD)-inducing doxorubicin prodrug YB NK Lee, YS Cho, I-S Kim Globalization of Pharmaceutics Education Network, 2018 | | 2018 |
In-San KimKorea Institute of Science and TechnologyE-mailová adresa ověřena na: kist.re.kr